Abstract
Objective To assess the association between 5-minutes Apgar score and neonatal survival among at-risk neonates.
Design Retrospective survival analysis.
Setting Ecuadorian neonates who died at ≤28 days of life.
Patients We analyzed the nationwide neonatal deaths registered by the Ministry of Public Health of Ecuador between January 2014 to September 2017.
Main outcome measures We performed a survival analysis and estimated adjusted hazard ratios (HR) per each 5-minutes Apgar score stratum, by Cox proportional hazards models.
Results We included in the study 2893 neonates, 1380 (48%) were female and had a median (P25 to P75) gestational age at birth of 31 (27 to 36) weeks. On univariate analyses, the median survival time in days of life was significantly longer per each increase in the 5-minutes Apgar score, as follows: 0.2 days for ≤4 points, 2 days for 5 points, 2.9 days for 6 points, 3.1 days for 7 points, 3.8 days for 8 points, 4.4 days for 9 points, and 5.5 days for 10 points. On multivariate analyses, and after adjusting for individual and contextual variables, and considering an Apgar score of 9 to 10 points as the reference, the HR was 32% (95% CI: 27% to 37%) higher per each decrease in the Apgar score category of two-to-three points (p-value for trend <0.01).
Conclusions There is a strong direct association between Apgar score at 5 minutes and neonatal survival in neonates considered at-risk. This association is independent of gestational age and other neonatal determinants of neonatal mortality.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was part of the Score Bebe project which was supported by Pontificia Universidad Catolica del Ecuador (Pontifical Catholic University of Ecuador) grant number QINV0025-IINV533010100.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was part of the Score Bebe project and conducted with the approval of the Research Ethics Committee in Human Beings (CEISH) of the Pontificia Universidad Catolica del Ecuador (code number: 2018-09-EO).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The Score Bebe project grants access to the main study results and data by making a request through the correspondence author.